Clinical Trial

PVI Alone vs PVI With Posterior Wall Isolation for Pulse-Field Ablation in Persistent AF

Study acronym: POBI-PFA
Enrolling by Invitation
View on ClinicalTrials.gov →
Summary
To date, no optimal treatment has been established to improve outcomes in patients with persistent atrial fibrillation. The safety and efficacy of pulsed-field ablation (PFA) have been demonstrated in several studies, and its clinical application is expanding. \- In patients with persistent atrial fibrillation, can the addition of posterior wall isolation (PWI) following pulmonary vein isolation (PVI) using PFA reduce recurrence? Participants will: * Undergo either PVI alone or PVI with additional left atrial posterior wall isolation (PWI) * Visit the clinic to assess for recurrence of atrial tachyarrhythmias
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-04-08.
Status change: Not Yet Recruiting → Enrolling by Invitation 2026-07-15
Trial Details
NCT Number NCT06929897
Lead Sponsor Ewha Womans University Mokdong Hospital
Collaborators: Ewha Womans University Seoul Hospital, Korea University Anam Hospital, Kangbuk Samsung Hospital, Asan Medical Center, Severance Hospital, Samsung Medical Center, Chonnam National University Hospital, Daegu Catholic University Medical Center
Conditions Atrial Fibrillation (AF)
Enrollment 482 participants
Start Date 2026-07-03
Primary Completion 2029-06-30 (estimated)
Study Completion 2029-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-07-16